Arming Immune Cells for Battle: A Brief Journey through the Advancements of T and NK Cell Immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cancers 13.6 (2021): 1481.
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2021
- Creator
-
Wendel, Philipp
Reindl, Lisa Marie
Bexte, Tobias
Künnemeyer, Leander
Särchen, Vinzenz
Albinger, Nawid
Mackensen, Andreas
Rettinger, Eva
Bopp, Tobias
Ullrich, Evelyn
- DOI
-
10.3390/cancers13061481
- URN
-
urn:nbn:de:bvb:29-opus4-162025
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:53 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wendel, Philipp
- Reindl, Lisa Marie
- Bexte, Tobias
- Künnemeyer, Leander
- Särchen, Vinzenz
- Albinger, Nawid
- Mackensen, Andreas
- Rettinger, Eva
- Bopp, Tobias
- Ullrich, Evelyn
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2021
Other Objects (12)
Unleashing the power of NK cells in anticancer immunotherapy
Mechanism and efficacy of a GD2-specific immunotherapy using NK cells
NK cell regulation
Tumor-priming converts NK cells to memory-like NK cells
Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
Current Advancements in Anti-Cancer Chimeric Antigen Receptor T Cell Immunotherapy and How Nanotechnology May Change the Game
NK cells in the liver
Use of TCR antibody fusion proteins as bispecific agents for NK and T cell-mediated immunotherapy
Mass production of highly active NK cells for cancer immunotherapy in a GMP conform perfusion bioreactor
Investigating tumor cell-specific barriers for immunotherapy
Restoring NK cells function against cancer.
Metabolics of Tissue resident NK cells
Unleashing the power of NK cells in anticancer immunotherapy
Mechanism and efficacy of a GD2-specific immunotherapy using NK cells
NK cell regulation
Tumor-priming converts NK cells to memory-like NK cells
Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
Current Advancements in Anti-Cancer Chimeric Antigen Receptor T Cell Immunotherapy and How Nanotechnology May Change the Game
NK cells in the liver
Use of TCR antibody fusion proteins as bispecific agents for NK and T cell-mediated immunotherapy
Mass production of highly active NK cells for cancer immunotherapy in a GMP conform perfusion bioreactor
Investigating tumor cell-specific barriers for immunotherapy
Restoring NK cells function against cancer.
Metabolics of Tissue resident NK cells
Unleashing the power of NK cells in anticancer immunotherapy
Mechanism and efficacy of a GD2-specific immunotherapy using NK cells
NK cell regulation
Tumor-priming converts NK cells to memory-like NK cells
Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy
Current Advancements in Anti-Cancer Chimeric Antigen Receptor T Cell Immunotherapy and How Nanotechnology May Change the Game
NK cells in the liver
Use of TCR antibody fusion proteins as bispecific agents for NK and T cell-mediated immunotherapy
Mass production of highly active NK cells for cancer immunotherapy in a GMP conform perfusion bioreactor
Investigating tumor cell-specific barriers for immunotherapy
Restoring NK cells function against cancer.